Literature DB >> 11698486

CD antigens 2001.

D Mason1, P André, A Bensussan, C Buckley, C Civin, E Clark, M de Haas, S Goyert, M Hadam, D Hart, V Horejsí, S Meuer, J Morrissey, R Schwartz-Albiez, S Shaw, D Simmons, M Uguccioni, E van der Schoot, E Vivier, H Zola.   

Abstract

This paper reviews the Seventh Human Leucocyte Differentiation Antigen (HLDA7) workshop. Due to the limitations of "blind" antibody screening, which had been evident at the previous meeting in 1996, participants at HLDA7 adopted a more selective approach to the choice of antibodies by identifying new CD specificities. This resulted in the addition of more than 80 new CD specificities. Plans for the eighth and subsequent workshops are also previewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698486

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia.

Authors:  S P Koerner; M C André; J S Leibold; P C Kousis; A Kübler; M Pal; S P Haen; H-J Bühring; L Grosse-Hovest; G Jung; H R Salih
Journal:  Leukemia       Date:  2016-07-20       Impact factor: 11.528

2.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.